BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10319298)

  • 1. Who should decide how effective cervical cancer screening will be?
    Austin RM
    J Reprod Med; 1999 Apr; 44(4):317-20. PubMed ID: 10319298
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for cervical cancer in the era of the HPV vaccine--the urgent need for both new screening guidelines and new biomarkers.
    Kiviat NB; Hawes SE; Feng Q
    J Natl Cancer Inst; 2008 Mar; 100(5):290-1. PubMed ID: 18314471
    [No Abstract]   [Full Text] [Related]  

  • 3. Does the increased sensitivity of the new Papanicolaou (Pap) tests improve the cost-effectiveness of screening for cervical cancer?
    Reust CE
    J Fam Pract; 2001 Feb; 50(2):175. PubMed ID: 11219567
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical inquiries. Should we discontinue Pap smear screening in women aged>65 years?
    Curran DR; Stigleman S; Neher JO
    J Fam Pract; 2004 Apr; 53(4):308-10. PubMed ID: 15068776
    [No Abstract]   [Full Text] [Related]  

  • 5. [Is cervical screening justified in adolescents?].
    Barrasso R; Monsonego J
    Contracept Fertil Sex; 1996 Feb; 24(2):101-3. PubMed ID: 8611929
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening for disease, cost-effectiveness, and guidelines.
    Meyer DL
    Prim Care; 1995 Dec; 22(4):591-9. PubMed ID: 8668731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer. Which test is best?
    Cahill BA
    Adv Nurse Pract; 2005 Jan; 13(1):71-4. PubMed ID: 15679298
    [No Abstract]   [Full Text] [Related]  

  • 8. Improving the sensitivity of cervical cytology: what are the issues?
    Myers ER
    Am J Manag Care; 2000 Jul; 6(7):838-40. PubMed ID: 11067380
    [No Abstract]   [Full Text] [Related]  

  • 9. New cervical cancer screening guidelines: the other side of group health care "rights".
    Austin RM
    Diagn Cytopathol; 2004 Mar; 30(3):208-10. PubMed ID: 14986304
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cost effectiveness of cervical cancer screening strategies in Tunisia].
    Hsaïri M; Fakhfakh R; Ghyoula M; Ben Abdallah M; Achour N
    Tunis Med; 2000 Oct; 78(10):557-61. PubMed ID: 11190738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV testing and cervical cancer screening: recommendations and practice patterns.
    Madom LM; Boardman LA
    Med Health R I; 2005 Oct; 88(10):362-3. PubMed ID: 16353376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and cost implications of new technologies for cervical cancer screening: the impact of test sensitivity.
    Hutchinson ML; Berger BM; Farber FL
    Am J Manag Care; 2000 Jul; 6(7):766-80. PubMed ID: 11067374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recommendations on cancer screening in the European Union. Advisory Committee on Cancer Prevention].
    Lynge E
    Ugeskr Laeger; 2002 Jan; 164(2):176-8. PubMed ID: 11831084
    [No Abstract]   [Full Text] [Related]  

  • 14. Vaccination against HPV: indications for women and the impact on the cervical screening programme.
    Heideman DA; Snijders PJ; Berkhof J; Verheijen RH; Helmerhorst TJ; Meijer CJ
    BJOG; 2008 Jul; 115(8):938-46. PubMed ID: 18651878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality control in cervical cancer screening: Brazilian experience.
    Collaço LM; de Noronha L; Bleggi-Torres LF; Pinheiro DL
    Acta Cytol; 2005; 49(6):694-6. PubMed ID: 16450916
    [No Abstract]   [Full Text] [Related]  

  • 16. HPV prevention and the promise of the new vaccines.
    Allred S; Cox JT; Mahoney M
    J Am Acad Nurse Pract; 2006; 18 Suppl 2():1-11. PubMed ID: 17474243
    [No Abstract]   [Full Text] [Related]  

  • 17. New guidelines recommend less frequent cervical cancer screening.
    McBride D
    ONS Connect; 2010 Feb; 25(2):21. PubMed ID: 20198830
    [No Abstract]   [Full Text] [Related]  

  • 18. Cervical cytology--cost effective considerations.
    Medley G; Drake M
    Aust Health Rev; 1982 May; 5(2):9-14. PubMed ID: 10309737
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of cervical cancer with screening programme in Branicevo District and cost-effectiveness analysis adjusted to the territory of the Republic of Serbia.
    Perovic S
    J BUON; 2009; 14(1):93-6. PubMed ID: 19373953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Screening for cancer: from guidelines to practice].
    Sasco AJ
    Bull Cancer; 2001 Jul; 88(7):643-4. PubMed ID: 11495814
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.